Merck and Blackstone enter research agreement to develop cancer therapy for $700 million

(Reuters) -Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy.

(Reporting by Sneha S K)

Brought to you by www.srnnews.com